New shot aims to tame hepatitis b in early human trial
Disease control
Not yet recruiting
This early-stage study tests a new injection called AHB-171 in 110 people, first in healthy volunteers and then in those with chronic hepatitis B. The main goals are to check safety and how the body processes the drug, with a first look at whether it can help control the virus. P…
Phase: PHASE1 • Sponsor: Ausper Biopharma Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC